loxiglumide

cholecystokinin ; Homo sapiens







54 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 16718754 Cholecystokinin hyperresponsiveness in functional dyspepsia. 2006 May 7 1
2 12120894 The influence of cholecystokinin on gastric myoelectrical activity in duodenal ulcer following Helicobacter pylori eradication--an electrogastrographic study. 2002 Jun 1
3 15570466 Loxiglumide Rotta research. 2002 May 1
4 11552906 The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease. 2001 Sep 1
5 11123709 Pharmacological and molecular characterization of muscular cholecystokinin receptors in the human lower oesophageal sphincter. 2000 Dec 1
6 9860397 Physiological role of cholecystokinin in gastroprotection in humans. 1998 Dec 1
7 9140152 Plasma concentrations of cholecystokinin and neurotensin in patients with cystic fibrosis. 1997 Apr 1
8 9277416 Regulation of gastric and pancreatic lipase secretion by CCK and cholinergic mechanisms in humans. 1997 Aug 1
9 9391249 Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. 1997 Oct 1
10 9406280 Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide. 1997 1
11 8613041 Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. 1996 May 2
12 8632648 Luminal cholecystokinin and gastrin cause gallbladder contraction. 1996 May 2
13 8689933 Effects of cholecystokinin and carbachol on membrane fluidity in pancreatic acini. 1996 Jul 2
14 8843769 Role of cholecystokinin as a regulator of solid and liquid gastric emptying in humans. 1996 Sep 1
15 8864420 Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation. 1996 Jul 1
16 9026479 Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids. 1996 Nov 1
17 7481540 Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. 1995 Aug 3
18 7748985 Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women. 1995 Mar 1 1
19 7768249 Effects of somatostatin and loxiglumide on gallbladder motility. 1995 1
20 7787215 Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. 1994 Dec 3
21 7958670 Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. 1994 Dec 1
22 8174988 Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. 1994 Apr 4
23 8185159 Effects of CCK on pancreatic function and morphology. 1994 Mar 23 1
24 8185162 Effect of cholecystokinin on gastric motility in humans. 1994 Mar 23 1
25 7904286 Cholecystokinin in the control of gastric acid secretion in humans. 1993 2
26 8317902 Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin--responsive human gastric adenocarcinoma cells in vitro. 1993 May-Jun 2
27 8386784 Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer. 1993 May 1
28 8406310 Cholecystokinin does not delay gastric emptying of regular meals in healthy humans. 1993 Aug 1
29 8447844 Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion. 1993 Jan 1
30 8472978 Cholecystokinin in the control of gastric acid secretion in man. 1993 Mar 2
31 8511500 Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans. 1993 May 3
32 1291406 Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist. 1992 2
33 1492852 Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man. 1992 Nov 2
34 1503487 [Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice]. 1992 Aug 3
35 1557335 Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers. 1992 3
36 1557514 Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation. 1992 Feb 18 3
37 1568575 Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. 1992 May 1
38 1634067 A physiological role for cholecystokinin as a regulator of gastrin secretion. 1992 Aug 1
39 1702077 Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. 1991 Feb 3
40 1752290 Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. 1991 Oct 3
41 1996640 Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. 1991 Feb 2
42 2015421 Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum. 1991 Feb 1
43 2019374 Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers. 1991 Jun 3
44 2022712 Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. 1991 May 3
45 2065926 Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. 1991 Aug 3
46 2227288 Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. 1990 Dec 1
47 2262057 Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man. 1990 4
48 2295294 Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying. 1990 Jan 1
49 2312719 Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. 1990 Mar 3
50 2340960 Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. 1990 1